Schedule 13G ownership disclosure

Fate Therapeutics Inc

Security class unavailable · CUSIP: 31189P102

Event date: 2023-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.3100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-23-000682
Form type
SC 13G/A
Filer
FATE THERAPEUTICS INC
CIK
CIK 1434316
Filed
Oct 10, 2023
Reporting period
Sep 30, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub